Gain Share Price
NASDAQ: GANX | Micro Cap | HealthcareGain Stock Performance
Gain Share Price Today
As of 19 November 2026, Gain Therapeutics, Inc.'s share price is $1.09. The stock opened at $1.21, compared to its previous close of $1.18. During today's trading session, Gain Therapeutics, Inc.'s share price traded between $1.09 and $1.21, with an average price of $1.15. Over the past 52 weeks, the stock has recorded a high of $4.33 and a low of $0.94. In terms of performance, Gain Therapeutics, Inc.'s share price has declined by 44.95% over the last six months and is down 68.81% on a year-on-year basis.
Gain Share Price Chart
Gain Quarterly Profit & Loss
All figures in USD
Gain Annual Profit & Loss
All figures in USD
Gain Balance Sheet
All figures in USD Million
Gain Cash Flow
All figures in USD Million
About Gain
Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.
Gain Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $1.18 | $1.09 | -3.96% |
Oct 2026 | $1.73 | $1.14 | -34.77% |
Sep 2026 | $1.81 | $1.74 | -6.20% |
Aug 2026 | $1.68 | $1.85 | +10.42% |
Jul 2026 | $2.04 | $1.68 | -17.20% |
Jun 2026 | $1.96 | $2.03 | +2.47% |
May 2026 | $1.83 | $1.98 | +4.76% |
Apr 2026 | $1.95 | $1.89 | -2.07% |
Mar 2026 | $2.54 | $1.93 | -26.05% |
Feb 2026 | $1.85 | $2.61 | +44.20% |
Jan 2026 | $3.20 | $1.81 | -43.88% |
Dec 2025 | $3.40 | $3.23 | -7.73% |